260 results on '"Modena, Piergiorgio"'
Search Results
2. How ten-years of reirradiation for paediatric high-grade glioma may shed light on first line treatment
3. Retrospective analysis on the consistency of MRI features with histological and molecular markers in diffuse intrinsic pontine glioma (DIPG)
4. Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group
5. Haploinsufficiency of AKT3 gene causing microcephaly and psychomotor delay in a patient with 1q43q44 microdeletion
6. Pediatric intracranial ependymoma: correlating signs and symptoms at recurrence with outcome in the second prospective AIEOP protocol follow-up
7. Pediatric extraspinal sacrococcygeal ependymoma (ESE): an Italian AIEOP experience of six cases and literature review
8. A Peculiar CLL Case with Complex Chromosome 6 Rearrangements and Refinement of All Breakpoints at the Gene Level by Genomic Array: A Case Report
9. MBNL2-ALK: A novel ALK fusion transcript in a sinonasal melanoma
10. De novo Xq21.31–q21.32 duplication in intellectual disability: a new report
11. Medulloblastoma at relapse: for which patients and which tumors reirradiation is the better choice
12. Supplementary Figure Legends from SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJ
13. Supplementary Figure 2 from SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJ
14. Supplementary Figure 1 from SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJ
15. Supplementary Figure 3 from SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJ
16. Supplementary Figure A from SMARCB1/INI1 Tumor Suppressor Gene Is Frequently Inactivated in Epithelioid Sarcomas
17. Supplementary Figure B from SMARCB1/INI1 Tumor Suppressor Gene Is Frequently Inactivated in Epithelioid Sarcomas
18. Figure Legends from SMARCB1/INI1 Tumor Suppressor Gene Is Frequently Inactivated in Epithelioid Sarcomas
19. Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study
20. Science and pseudo science: racist eugenics in Italy
21. Ependymomas
22. Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology
23. The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants
24. Optimising biomarkers for accurate ependymoma diagnosis, prognostication and stratification within International Clinical Trials: A BIOMECA study
25. Celiac disease prevalence and predisposing‐HLA in a cohort of 93 Williams‐Beuren syndrome patients
26. Interhemispheric Pediatric Meningioma, YAP1 Fusion-Positive
27. A microRNA Prognostic Signature in Patients with Diffuse Intrinsic Pontine Gliomas through Non-Invasive Liquid Biopsy
28. SIOP Ependymoma I: Final results, long term follow-up and molecular analysis of the trial cohort: A BIOMECA Consortium Study
29. How ten-years of reirradiation for paediatric high-grade glioma can shed light on first line treatment
30. DIPG-04. Feasibility and early results of phase 2 open label randomized study of radiotherapy(RT), concomitant nimotuzumab and vinorelbine and re-irradiation at relapse, versus multiple elective radiotherapy courses with concomitant vinorelbine and nimotuzumab for newly diagnosed childhood and adolescence Diffuse intrinsic Pontine Glioma (DIPG)
31. EPEN-24. Biological markers of ependymoma in children and adolescents (BIOMECA): Systematic comparison of methods for the precise evaluation of biomarkers for ependymoma diagnosis and prognostication
32. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
33. Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
34. Prognostic determinants in epithelioid sarcoma
35. Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
36. Frequent Amplification of a chr19q13.41 MicroRNA Polycistron in Aggressive Primitive Neuroectodermal Brain Tumors
37. Epithelioid Soft Tissue Tumors
38. Translocation-Related Sarcomas
39. EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues
40. Celiac disease prevalence and predisposing‐HLA in a cohort of 93 Williams‐Beuren syndrome patients.
41. Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience
42. Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocol
43. A lower-dose, lower-toxicity cisplatin–etoposide regimen for childhood progressive low-grade glioma
44. Ultrastructural evidence of ependymal differentiation in a genetically proven atypical teratoid/rhabdoid tumor
45. Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS)
46. SIOP Ependymoma I: Final results, long term follow-up and molecular analysis of the trial cohort: A BIOMECA Consortium Study
47. Correction: SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJ
48. EPEN-04. SIOP EPENDYMOMA I: FINAL RESULTS, LONG TERM FOLLOW-UP AND MOLECULAR ANALYSIS OF THE TRIAL COHORT: A BIOMECA CONSORTIUM STUDY
49. Second series by the Italian Association of Pediatric Hematology and Oncology of children and adolescents with intracranial ependymoma: an integrated molecular and clinical characterization with a long-term follow-up
50. La tecnologia genetica: ciò che ogni pediatra dovrebbe sapere
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.